Autoimmune Diseases  >>  mavrilimumab (KPL-301)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
mavrilimumab (KPL-301) / Kiniksa
NCT00771420: A Single Dose Study of the CAM-3001 in Patients With Rheumatoid Arthritis

Checkmark Data
May 2011 - May 2011: Data
Completed
1
38
Europe
CAM-3001, Mavrilimumab, Mavriliumab, Placebo
MedImmune Ltd
Rheumatoid Arthritis
12/08
02/09

Download Options